A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Doctors at Dana-Farber say this personalized vaccine can be given after surgery to remove a tumor and train the body’s immune ...